CXCR4 and glioma: Cell invasion analyses showed that D609 was able to induce a stronger inhibition of U87MG cell invasion (46%) compared with that induced by the conventional CXCR4 antagonist (38%) (Fig 3B), which proved to inhibit glioma cell motility [8,30].